glp 1 agonist and weight loss GLP-1 agonists for loss: What you need to know Balancing weight and muscle loss
Description
Given obesitys role in more than 200 chronic diseases, including diabetes and cardiovascular conditions, the reduction of obesity rates translates into long-term savings for healthcare systems
What studies show: People can lose ~15% of their body weight on average with semaglutide The catch: Once the drug is stopped, weight regain is common most people regain much of their lost weight within a year
The key results from CVOTs for various GLP-1 RAs are presented in Table 16
The proportional hazards assumption was evaluated by examining the scaled Schoenfeld residuals of each variable ( Finally, to examine a possible additive effect of GLP-1 RAs on fracture risk, we used Aalens additive hazards regression model
